Stay updated on Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.

Latest updates to the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov 403 Forbidden page, announcing a terminology change from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check10 days agoChange DetectedThe ClinicalTrials.gov error page displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the access-denied page.SummaryDifference0.2%

- Check38 days agoChange DetectedA 403 Forbidden error page now appears for the study record, replacing the usual content with an access-notice. The page shows a 403 header and related messaging, indicating access is blocked.SummaryDifference20%

- Check59 days agoChange DetectedA new NIH grant line for 2015 was added, and the page's revision indicator was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a system-level update. No visible content or functionality changes are indicated in the provided changes.SummaryDifference0.0%

Stay in the know with updates to Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long Term Extension of Risankizumab in Crohn's Disease Clinical Trial page.